MedPath

Evaluation of the Vascutek Ltd. Thoracic Endovascular Stent Graft System (Thoraflex) in the Treatment of Aneurysm or Penetrating Ulcer of the Descending Thoracic Aorta

Completed
Conditions
Thoracic aneurysm
10002363
Registration Number
NL-OMON36276
Lead Sponsor
Vascutek Limited
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
22
Inclusion Criteria

Patients with aneurysms or penetrating ulcers of the descending thoracic aorta;Main
1.Subject ages > 18 years
2.Subject has a life expectancy of at least 12 months
3.The Subject must meet at least one of the following:
- Descending thoracic fusiform aneurysm, 50mm in diameter or greater.
- Descending thoracic aneurysm that is 4cm or more in diameter that has increased in size by 0.5cm in last 6 months
- Descending thoracic aneurysm with a maximum diameter that exceeds two times the diameter of the non-aneurysmal, adjacent aorta
- Saccular aneurysm in the descending thoracic aorta or Penetrating Atherosclerotic Ulcers (PAUs)
4. The diagnosis is confirmed as thoracic aortic aneurysm or PAU by contrast enhanced CT obtained within the three months prior to implant.
(all 9 inclusion criteria can be found in the protocol section 5.1)

Exclusion Criteria

Main exclusion cirteria:
1. Subject has any of the following conditions in his/her descending thoracic aorta:
- Dissections - acute or chronic, in ascending or descending aorta
- Acute Transection or Acute Traumatic Injury
- Pseudoaneurysm (false aneurysm)
- Symptomatic Aneurysm, including ruptured lesions
2. Subject's proximal neck diameter, < 22 or > 35 mm.
3. Subject's distal neck diameter, < 22 or > 35 mm.
4. Subject has prohabitive calcification(>50% circumferential calcification), occulsive disease or tortuosity of intended fixation sites.
(All 25 exclusion criteria can be found in the protocol section 5.2)

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath